Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00032370 · ClinicalTrials.gov registry record · NA
Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality
A NA study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 510
- Enrollment target
NCT00032370 is a NA study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 510 participants.
The verdict
NCT00032370, a NA study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 510 participants
- Enrollment target
Study Summary
Although a number of sophisticated diagnostic tests have been shown to be helpful in identifying patients at high risk for perioperative cardiac complications, no study has addressed the most important question: Should prophylactic coronary revascularization be performed prior to elective vascular surgery? This study is designed to answer this question.
Interventions
- PROCEDURE Coronary artery bypass grafting (CABG)
- PROCEDURE Vascular surgery with best medical treatment
- PROCEDURE Percutaneous transluminal coronary angioplasty (PTCA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 1997-08 |
| Est. Completion | 2004-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00032370
The ClinicalTrials.gov registry entry for NCT00032370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is US Department of Veterans Affairs, which has 632 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Coronary artery bypass grafting (CABG) is the first listed.
NCT00032370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00032370 about?
NCT00032370 is a clinical study titled "Does Prophylactic Coronary Artery Revascularization for High Risk Patients Reduce Long-term Risk of Mortality". Although a number of sophisticated diagnostic tests have been shown to be helpful in identifying patients at high risk for perioperative cardiac complications, no study has addressed the most important question: Should prophylactic coronary revascularization be performed prior to elective vascular s...
What is the current status of trial NCT00032370?
This trial is currently completed. It is a NA study. The enrollment target is 510 participants. The study started on 1997-08. Estimated completion is 2004-05.
What interventions are being tested in trial NCT00032370?
The interventions under investigation include: Coronary artery bypass grafting (CABG) (PROCEDURE), Vascular surgery with best medical treatment (PROCEDURE), Percutaneous transluminal coronary angioplasty (PTCA) (PROCEDURE).
Who is sponsoring clinical trial NCT00032370?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.